Article
Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial.
Oxidative medicine and cellular longevity - 1 Jan 2022
Ahmed Sarfraz, Ullah Najeeb, Parveen Sadia, Javed Ifra, Jalil Nur Asyilla Che, Murtey Mogana Das, Sheikh Irfan Shahzad, Khan Shahroz, Ojha Suvash Chandra, Chen Ke
Abstract excerpt
Silymarin is proclaimed to be a blend of flavonolignans or phytochemicals. An era of new generation of direct-acting antivirals (DAAs) has commenced to have facet effect in swaying of the hepatitis C virus (HCV). Nonetheless, this therapy has serious side effects that jeopardize its efficacy. This study is aimed at probing the effects of ribavirin (RBV) and sofosbuvir (SOF) along with silymarin as an adjunct...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.